Orphan Drugs Worth $64 Billion by 2028 and This Micro Cap Could Have One by That Time
07 Novembro 2023 - 6:01PM
AllPennyStocks.com
There are very good reasons that stocks
generally gain in value after a company receives orphan drug
designation (ODD). A
To read the full story on AllPennyStocks.com, click
here.
Nurexone Biologic (TSXV:NRX)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Nurexone Biologic (TSXV:NRX)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
